Articles
If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.
MoCRA Updates
On Friday, Sep. 15, 2023, the FDA posted draft screenshots of the electronic submission portal – Cosmetics Direct – that will enable companies to organize and compile information needed to file facility registration and product listing submissions come Oct. 2023....
MoCRA Updates
To facilitate cosmetic product facility registration and product listing submissions as mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), the FDA intends to make a new electronic submission portal available in October 2023. Although, FDA...
Getting prepared for MoCRA by Dec. 29, 2023
With the upcoming deadline for complying with MoCRA requirements quickly approaching, it is important for beauty brands to undertake certain actions in order to be prepared. A few changes that MoCRA necessitates include mandatory registration of cosmetic facilities...
Proposed Cosmetic Ingredient Updates
Health Canada has proposed updates to the Cosmetic Ingredient Hotlist and the consultation has now been posted for comments until 11 October 2023. The proposed updates include additions to the Hotlist as well as revisions to some existing entries including...
Cosmetics Animal Testing Ban
The ban on animal testing for cosmetics has introduced several important requirements for manufacturers and brand owners. While most cosmetics do not necessitate the submission of safety evidence, it is the responsibility of the manufacturer or brand owner to ensure...
NEW Section 71 Mandatory Survey
A recently published mandatory survey under CEPA paragraph 71(1)(b) requires that industry report certain information related to substances listed in the notice no later than January 17, 2024. The stated purpose is to support the government’s prioritization...
Proposed Food and Drugs Act amendments say NHPs to be under the definition of ‘therapeutic product’
The proposed amendments to the Food and Drugs Act (FDA) in Bill C-47 mainly focus on encompassing Natural Health Products under the ‘therapeutic product’ definition, empowering the Minister of Health to have more authority to deal with therapeutic products that may...
Proposed Fees for Natural Health Products
Currently in Canada, there are no Health Canada fees charged in relation to Natural Health Products (NHPs). In May 2023, Health Canada proposed implementing cost recovery fees to enhance regulatory oversight and streamline the approval processes for NHPs. The proposed...
Passage of Strengthening Environmental Protection for a Healthier Canada Act
Strengthening Environmental Protection for a Healthier Canada Act (Bill S-5), the legislation amending the Canadian Environmental Protection Act (CEPA) has been recently passed by the Senate. This bill was first introduced last year to modernize CEPA since its...
The Modernization of Cosmetics Regulation Act of 2022 (“MoCRA”)
On December 29, 2022, President Joe Biden signed into law the Consolidated Appropriations Act, 2023, which includes the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). This new cosmetic legislation establishes federal standards for cosmetic business...
“Focal Point Research has consistently and professionally looked after regulatory and quality issues of our brand for years. Through a courteous and knowledgeable team, they have managed to navigate us through an ever changing regulatory landscape while maintaining our interests, and allowed us to correctly distribute and sell within Canada.”
“I have truly enjoyed working with you over the last 8 years! You and your team have been an amazing resource for me. I have always been impressed by the knowledge and professionalism of everyone at Focal Point, which is a true testament to your leadership.”
Connect With Us
The Focal Point Research team is ready to help with all of your scientific and regulatory needs. Our team has the experience and expertise you need to see your product to market and we are eager to help you.
